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B cell development is often portrayed as a series of deci-
sion points that expand an antigen-reactive cell to a clone
producing a single antibody. This is hardly the case: B cell
development is dependent on a series of error-prone, ran-
dom rearrangement events that through ongoing diversifi-
cation reach a compromise in which most cells are not au-
toreactive (except in disease) and the majority of clone
members remain specific for the initial antigen. One famil-
iar example of ongoing diversification is somatic mutation
during clonal expansion (1). Another example, receptor
editing, is the means by which immature bone marrow B
cells become self-tolerant (2–4). Here rearrangements are
induced by encounter with autoantigens to change speci-
ficity from self to non-self. Now, a third level of diversifi-
cation, termed “receptor revision,” has been suggested to
occur in mature B cells. Initial evidence for revision in-
cluded recombination activating gene (RAG) expression in
germinal centers along with attendant double-stranded
breaks adjacent to recombination signal sequences (RSS)
(5–7), but the strongest evidence comes from examples of
cells that underwent revision after somatic mutation was
initiated. The paper in this issue by Wilson et al. (8), along
with two previous studies (9, 10), identifies clones of B
cells that include cells whose antibody genes have under-
gone concurrent mutation and revision.
 
These findings place receptor revision firmly into the en-
vironment of germinal centers. In addition to somatic mu-
tation, this is where other important immunological pro-
cesses happen, including H chain class switch and immune
memory formation. The germinal center cell subset that
expresses most RAG activity appears to be the noncycling,
centrocyte cells (5, 11). Unlike other peripheral B cells,
these cells express many markers shared by bone marrow B
cells, including surrogate L chain components, IL-7R, and
in humans, terminal deoxynucleotidyl transferase (6, 11,
 
12). Furthermore, purified IgD
 
1
 
 splenic B cells express
RAG upon exposure either to a combination of CD40 an-
tibodies and IL-4 (agents that are thought to mimic T cell
help), or to a combination of LPS and IL-4 (7). More re-
cent studies show that IL-7, rather than IL-4, may be the
critical cytokine driving receptor revision in vivo since
RAG expression is unperturbed in the germinal centers of
immunized IL-4–deficient mice, but is blocked in anti–IL-
7R–treated mice (12). Interestingly, IL-7 is also a key cy-
tokine for immature B cell expansion. These parallels be-
tween the cells undergoing receptor revision and immature
B cells supported the idea that germinal center B cells rein-
duce a gene expression program characteristic of less mature
cells, a concept known as “neoteny” (5). Reprogramming
might be initiated by a lethal mutation in VH or VL. Such a
mutant might resemble a pro-B or pre-B cell, and other
phenotypes such as RAG expression might be activated.
 
The similarities between RAG-expressing bone marrow
and germinal center B cells raise the possibility that receptor
editing is going on in immature B cells that have migrated
to the periphery. Three recent papers examining RAG in-
dicator mice (13–15) reinforce this concern. Nussenzweig
and colleagues generated bac-transgenic mice expressing a
green fluorescent protein (GFP) gene placed in the context
 
of 
 
z
 
100 kb of the RAG gene cis-acting elements (13).
Here, the cells expressing GFP in the periphery had the
phenotype of newly minted bone marrow B cells, not ger-
minal center cells. Furthermore, stimuli that were thought
to increase RAG expression in vitro or in vivo failed to
demonstrate upregulation of GFP and may just have pro-
longed expression in immature cells that were initially
 
GFP
 
1
 
 (13). A second mouse made by Alt and colleagues
targeted the endogenous RAG-2 gene to generate a RAG-
2–GFP fusion protein in the natural locus (14). This gene
proved to be functional in the homozygous mice, which
generated B and T cells. Because RAG-2 is in part regulated
at the level of protein stability (16), these mice, unlike the
bac-GFP mice, rapidly lose GFP protein with B cell matu-
ration. Upon immunization to generate germinal centers,
RAG expression was found, but appeared mainly in cells
with little or no surface (s)Ig (14). It remains to be seen if
these cells are typical germinal center cells. In a third study,
Sakaguchi and colleagues (15) targeted GFP to the RAG-1
locus and studied its expression in B-1 cells, which had been
reported previously to express RAG (17). As in the previous
study, RAG was expressed in just 1% of peritoneal (CD5
 
1
 
)
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B-1 cells, but was found in a large subset of apparently
newly formed B-2 cells. These studies say that few B cells
reinitiate V(D)J recombination in the peripheral lymphoid
system, and suggest that cells expressing RAG in the periph-
ery are phenotypically immature. To reconcile these studies
with those that demonstrate revision in cells undergoing hy-
permutation, one must assume either that immature B cells
can participate in germinal center reactions or that germinal
center B cells that revise are rare or difficult to detect.
Since peripheral B cells that express RAG seem to be a
heterogeneous population including both immature bone
marrow emigrants and germinal center–like cells, other
properties (besides RAG expression) that distinguish ma-
ture and immature B cells must be considered to appreciate
the role and significance of receptor revision. Several lines
of evidence suggest that revision and editing, though simi-
lar in many ways, are distinct in much more than the ana-
tomical location of the recombinationally active cells, par-
ticularly with respect to the consequences of antigen
receptor signaling. First, when appropriately stimulated
such as with LPS plus IL-4, mature but not immature B
cells rapidly express RAGs and other germinal center
markers shared with bone marrow B cells, including GL-7
and IL-7R (12, 18, 19). Importantly, addition of cognate
antigens or B cell antigen receptor (BCR) antibodies to
such cultures prevents RAG induction (11, 20). On the
other hand, simple BCR ligation induces editing in imma-
ture but not mature B cells, even when both types of cells
are present together in the same microenvironment (21,
22). These studies appear to rule out a direct role of recep-
tor revision in immune tolerance.
Another possible difference revealed in the Wilson et al.
study (8) is V gene replacement at the H chain. Receptor
editing was originally found at L chain loci (2–4). Second-
ary rearrangements at the 
 
k
 
 locus replaced a V
 
k
 
J
 
k
 
 gene that
contributed to the self-specificity of a BCR by another V
 
k
 
rearrangement to J
 
k
 
 (genotypic editing, see Fig. 2) or
formed a second, functional VJ allele that produced an L
chain that could outcompete the first for association with
the H chain (phenotypic editing; here the extent to which
the edited B cell appears to be allelically excluded depends
on the competitive advantage of the L chain for H chain).
Two properties of L chain genes not shared with H chain
loci seemed to favor editing of this subunit. The first is the
grand organization of the 
 
k
 
 locus: the asymmetry of the
RSS of V
 
k
 
’s and J
 
k
 
’s allows secondary rearrangement of
V
 
k
 
’s upstream of and J
 
k
 
’s downstream of the primary V
 
k
 
J
 
k
 
rearrangement (Fig. 1 and Fig. 2 A). In theory, a 
 
k
 
 allele
could undergo up to five rearrangements (if one includes
V
 
k
 
 rearrangement to the C
 
k
 
 deleting elements [
 
k
 
de]). Sec-
ondary rearrangements are sustained not just by multi-V
 
k
 
and J
 
k
 
 loci, but also by the orientation of V
 
k
 
 genes.
Whereas most V genes, VH for example, are oriented vis a
vis J so as to delete intervening DNA upon rearrangement
(23, 24), V
 
k
 
 genes are oriented in both directions (25–27).
Hence, about half of V
 
k
 
’s invert intervening DNA,
thereby conserving V
 
k
 
’s that lie in the intervening DNA
and converting deletion-oriented V
 
k
 
’s to inversional V
 
k
 
’s.
 
This flip-flop potential optimizes the V repertoire for edit-
ing (Fig. 2 B). DNA deleting events also occur, leading to a
directionality of rearrangement; hence a hallmark of editing
in B (or T cells) is a bias toward downstream J genes and
depletion of V genes.
The second relevant property of L chains is that they are
usually encoded by two or more autonomously expressed
loci: 
 
k
 
, 
 
l
 
1, 
 
l
 
2, etc. Multiple L chain loci (isotypes) also in-
crease editing opportunities: if one isotype is terminally—
but unsuccessfully—rearranged, then the other can take its
place. Indeed, the editing potential of two isotypes is opti-
mized by sequential rearrangement, i.e., 
 
k
 
 before 
 
l
 
 (28). In
humans, this transition opens a large (
 
z
 
70) V
 
l
 
 gene library
for further diversification and editing (29), but in the
mouse the transition offers little variety. Yet mouse immu-
nity is fine without 
 
l
 
, so the foreshortened mouse 
 
l
 
 serves
Figure 1. Organization of antibody genes. Gene segment numbers
for humans and mice are indicated as n man/n mouse. Sequences in-
volved in recombination are designated: c, 2 turn RSS; x, 1 turn RSS;
striped v, k deleting element (kde); ., VH central embedded heptamer
(59-CACAGTG-39); and ,, VH terminal embedded heptamer (59-
TACTGTG-39).
Figure 2. V gene editing at a k-like L chain locus. V gene replacement
can occur by secondary VJ rearrangement since the V RSS and J RSS are
asymmetric, i.e. fit the 1 turn/2 turn or 12/23 bp rule. V genes in the
same transcriptional orientation as J such as V1 and V2 delete DNA upon
rearrangement (A). V3 and V4 invert the DNA between V and J, thereby
conserving V genes (B). Moreover, V genes in the deletionogenic orien-
tation such as V1 and V2 are now turned around and will conserve DNA
on subsequent rearrangement. 
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mainly to rescue 
 
k
 
-deleted B cells from oblivion. In the
same sense that tolerance by editing influences J
 
k
 
 usage, it
drives the repertoire toward 
 
l
 
.
H chain genes do not have these features. V(D)J gene re-
placement by secondary VH to JH cannot work because the
VH and JH RSS do not meet the 1 turn/2 turn require-
ment for recombination and because D segments, the
guardians of this rule, are deleted by the primary V(D)J re-
combination (Fig. 3). But various types of recombination
and H chain modification hinted that editing might be pos-
sible. Artificial recombination substrates have shown that
the 1 turn/2 turn rule is relaxed and that heptamers alone
can serve as recombination targets (30). B cell lymphomas
constitutive for recombination provided in vivo evidence
for VH gene replacement at a heptamer embedded in the
primary V(D)J rearrangement (31, 32). This phenomenon
inspired surveys of VH genes for RSS-like sequences that
showed remarkable conservation (and presumed signifi-
cance) of the heptamer embedded at the end of most VH
genes (33). Yet VH replacement as seen in VH transgenic
mice suggested that VH replacement occurred early, at the
pro-B stage, and could simply be a variation of primary
V(D)J recombination played out on an inherited V(D)J sub-
strate (34). Wilson et al. (8) now show that VH replacement
is real, may happen often, and can work in strange ways.
The functional VH replacements described so far have
used an embedded heptamer at the end of framework re-
gion 3 (FR3) that is oriented in the same direction as those
RSS to which VH ordinarily rearranges, for example, VH
to (D)J. The example described by Wilson et al. (8) uses
the heptamer located at the beginning of FR3 of VH, but
this heptamer points in the opposite direction (Fig. 3). Wil-
son et al. reason that VH replacement can happen at this
site through hybrid joint formation. This is one of the four
possible products of the recombination intermediate that
are detected in in vitro recombination systems and one that
nicely explains the VH chimera (30). Similar chimeric VHs
are seen in expanded B cell clones found in synovia of
rheumatoid arthritis (RA) patients and here VH replace-
ments at both heptamers are found (Chiorazzi, N., manu-
script in preparation). Wilson et al. (8) argue that VH revi-
sion may be common but unrecognized. For example, VH
replacement at the downstream heptamer is essentially “in-
visible,” since most of the recipient gene is erased. Another
perhaps much more profound reason for underestimating
the extent of VH editing is that VH lacks the backup
Figure 3. VH replacement. Secondary VH rearrangement to embedded heptamers can replace most of a V(D)J if at the VH terminal heptamer, or
about half of the V(D)J if at the central heptamer (B). In the former case, DNA between the donor and recipient VHs is deleted since most VH genes are
in the same transcriptional orientation as JH (A). But DNA can be inverted if the initial rearrangement is VH to the 39 RSS of D (B). This inverts inter-
vening DNA and would allow a VH1 replacement of a VH2 (D)J, as observed by Wilson et al. (reference 8).
Figure 4. Rearrangement
events at an H chain locus. Rear-
rangement occurs on both alleles,
leading to a B cell with a V(D)J
allele and a (D)J allele. If rear-
rangement can resume at both al-
leles, then allele 1 might be re-
placed and allele 2 might undergo
further (D)J rearrangements. If
allele 1 becomes nonfunctional
during clonal expansion, then al-
lele 2 can become functional by a
V to (D)J event. Such V(D)Js
should be enriched for down-
stream JHs. 
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equipment that L chain has. In effect, VH editing has one
shot, and given the high likelihood of out-of-frame joins
and inadvertent use of a pseudo V for replacement, success-
ful VH replacement happens at best 20% of the time. In ad-
dition, VH genes include cryptic heptamers that have been
shown to act as replacement targets but that lead to abnor-
mal VH sequences (35). Taken together, these factors con-
spire against successful editing and the apparent preference
for L chain editing is mainly due to the loss of B cells with
two defunct VH alleles.
Of course, the key distinction between editing and revi-
sion is the setting in which revision appears to happen. The
examples reported so far are in highly expanded clones as
judged by the high frequency of mutations. This correla-
tion suggests that revision may be a rare event and apparent
only in special circumstances such as chronic antigen drive
or autoimmunity. An example of the latter is found in the
MRL mouse. Monestier and colleagues show that the un-
usual H chain junctions of autoantibodies resulting from
DD fusion and D inversions (Fig. 4) are formed extensively
in this strain (36). Since these unusual junctions are already
found in preimmune B cells, they interpret this to mean
that the D to J window of rearrangement is extended in au-
toimmunity. This idea helps to explain why autoantibodies
are heavily biased in favor of JH4 (mouse) or JH5 and JH6
(humans). The bias is a puzzle because secondary V to J re-
arrangements as at the 
 
k
 
 locus (Fig. 2) are not possible after
the primary VHDHJH rearrangement (Fig. 3). But, as
shown in Fig. 4, the bias can be understood by extended
rearrangement at the D to J stage. During clonal expansion,
lethal mutation or aberrant editing kills the primary V(D)J
(allele 1, Fig. 4) but the cell can be rescued by rearranging
allele 2. In the interim, this allele may have undergone sev-
eral introductory DJ rearrangements that might have led
(especially in MRL mice) to DJ4 or DDJ4 (Fig. 4). There is
evidence for extended receptor editing in cells that overex-
press cell survival proteins (37–39), and receptor revision
has been seen in Fas-deficient (
 
lpr/lpr
 
) mice (9), lupus (40),
and RA (Chiorazzi, N., manuscript in preparation).
The differential regulation of revision and editing by the
antigen receptor predicts far-reaching effects on immune
tolerance. Editing minimizes autoreactivity in immature,
preimmune cells by specifically replacing autoreactive re-
ceptors, whereas revision occurs during antigen-driven
immune responses and is suppressed, rather than induced,
by sIg cross-linking. Therefore, revision, unlike editing,
should complicate immune tolerance by generating new,
often autoreactive receptors in activated, mature B cells. As
a consequence, revision may be associated with autoimmu-
nity for two reasons: extended clonal expansion (as in dis-
ease) may be necessary to realize significant frequencies of
revision and when revision occurs, virgin repertoires that
include autoantibodies are generated. Furthermore, be-
cause of their differential sensitivity to BCR signaling, revi-
sion and editing also differ in their predicted impact upon
“allelic and isotypic (
 
k
 
 or 
 
l
 
) exclusion,” i.e., the propensity
of cells to express at any given time a single pair of antibody
H and L chains. Receptor editing that is stimulated by an
 
autoreactive receptor is geared to promote continued sec-
ondary Ig L gene rearrangements until the offending recep-
tor is eliminated or altered. This automatically diminishes
double producers, at least in terms of cell surface expres-
sion. But because receptor revision in antigen-activated
cells is suppressed by sIg binding (11, 20), revision should
allow multiple receptor production and that could lead to
gratuitous autoantibody expression.
How can the phenomena of receptor editing and revi-
sion, which (along with somatic hypermutation) may be
lumped under the rubric of “receptor selection,” be recon-
ciled with the concept of “clonal selection”? Rather than
being viewed as mutually exclusive pathways, these mecha-
nisms complement each other by regulating independently
the survival and propagation of cells and their receptors. In
promoting lymphocyte cell death or proliferation, clonal se-
lection reduces diversity, whereas receptor selection mecha-
nisms enhance diversity. When receptors are autoreactive,
receptor selection can destroy them, while often sparing the
cell. If an antigen-reactive cell has made a useful improve-
ment in specificity, then that specificity can be fixed, facili-
tating clonal expansion. On the other hand, if antigen reac-
tivity is weak, receptor selection allows specificity to drift,
sometimes generating saltatory improvements in antigen
binding affinity, albeit rarely, but at other times generating
self-reactive cells, which may in turn need to be controlled
by clonal mechanisms. Working together, receptor selec-
tion and clonal selection account for the astonishing rapid-
ity of the somatic evolution of immune specificity.
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